Table 2.
Mycotoxin | Species | Dose | Exposure | Main Findings with Respect to Leydig Cells | Ref. |
---|---|---|---|---|---|
AFB1 | Mouse | 50 μg/kg BW * | 45 days | Upregulation of genes involved in cell differentiation, extracellular space, and immunity | [126] |
Rat | 0–10 μM | 35 days | Extra-hepatic toxicity by inhibition of proteins involved in androgen biosynthesis such as StAR, HSDB3, and HSD17B3 | [125] | |
CTN | 50 and 100 μM | 36 h | Reduced testosterone secretion Induced apoptosis |
[127] | |
T-2 | Mouse | 1–102 μM | 24 h | Dose-dependent decrease in testosterone levels | [128] |
ZEA | 0–20 μg/mL (0–62.3 μM) | 1–24 h | Dose- and time-dependent inhibition of testosterone stimulated by both hCG and cAMP | [130] | |
0.01–100 μM | 24 h | Suppressed hCG-induced testosterone secretion | [129] | ||
5 μM | 24 h | Modified mitochondrial lipid metabolism Increased energy production Inhibited steroidogenesis and esterification |
[132] | ||
0–200 μg/mL (0–623 μM) | 24 h | ER stress pathway activated in ZEA-induced apoptosis | [133] | ||
Rat | 2.5–20 μg/mL (7.8–62.3 μM) | 12 h | Investigation of anti-ZEA compounds | [134] |
* In vivo study; AFB1—aflatoxin B1; CTN—citrinin; T-2—trichothecene-2; ZEA—zearalenone. In parentheses, measures converted to μM.